Video Colonoscopes – i10 Series HD+
The i10 Series HD+ Colonoscopes are PENTAX Medical’s premium line of endoscopes for screening, diagnostic and therapeutic treatment in the lower GI tract. The i10 Colonoscopes are available in both standard and slim insertion tube diameters and both equipped with a large 3.8mm instrument channel. The i10 Series HD+ Colonoscopes deliver the best imaging, therapeutic opportunity and ergonomic comfort within the PENTAX Medical Colonoscopy Product Line.
Next generation imaging system with HD+™ CCDs, CloseFocus™ and i-SCAN™
The i10 Series HD+ Colonoscopes are equipped with second-generation HD+ Megapixel Resolution CCDs for exceptional image clarity and detail resolution. Both scopes can be used with i-SCAN™ image enhancement technology that provides the user with an enhanced view of the texture of the mucosal surface and the blood vessels. The EC34-i10L features CloseFocus™ Examination Range allows the physician to get as close as 2mm from the mucosa for even greater resolving power and magnified visualization of the tissue and capillary networks automatically, without the need for button activation.
Improved ergonomic design and control
Endoscopist’s daily procedure volume is growing and putting more pressure on the endoscopist to do more cases and reduce procedure times. The i10 Series HD+ Colonoscopes are designed with a new ergonomic control body to better support higher case volumes and overall comfort in the physician’s hand. With PENTAX Medical i-FLEX™ Graduated Stiffness Insertion Tubes featuring TrueTorque™ Design, the i10 Series HD+ Colonoscopes are designed to balance efficiency, consistency and patient comfort in colonoscopy.
PENTAX Medical celebrates 100-year anniversary and donates $125,000 from its successful MILES FOR HEALTH™ campaign
The MILES FOR HEALTH™campaign highlighted the importance of cancer research around the globe and raised $125,000 for World Cancer Research Fund.
Tokyo, Japan (6 December 2019) – PENTAX Medical, a leading provider of endo-imaging solutions, celebrates the 100th anniversary of the foundation of Asahi Optical Joint Stock Co., the original manufacturer of PENTAX-branded products. Through its successful MILES FOR HEALTH™ - 100 Years of PENTAX campaign, PENTAX Medical has raised $125,000 for World Cancer Research Fund, reflecting the company’s historical and ongoing commitment to help improve the awareness, detection, diagnosis and treatment of cancer.
Staff, partners and customers of PENTAX Medical all took part in pledging their “MILES FOR HEALTH”, from distances of one mile to a marathon and via any method of self-propulsion, including walking, running and cycling. In addition to a $100,000 donation to commemorate its achievement of 100 years since its origin, PENTAX Medical added a further $1 for every mile travelled. This was then rounded up to take the total amount for World Cancer Research Fund to $125,000. At the United European Gastroenterology Week (UEGW) in Barcelona, Spain, 19-23 October, attendees took part in an organized fun run and joined in using an on-booth running machine, with all proceeds going to the MILES FOR HEALTH campaign.
On 12th November 2019, Gerald W. Bottero, Global President, PENTAX Medical was accompanied by representatives from all regional leadership teams to present a cheque for $100,000 to Dr. Shoichiro Tsugane from World Cancer Research Fund at the global headquarters of PENTAX Medical in Tokyo, Japan. “Our MILES FOR HEALTH campaign has been a huge success. Not only have we, as a company, raised a large sum of money for a truly worthwhile cause, but we have worked alongside the campaign to raise awareness of the vital need for cancer research - a value at the core of PENTAX Medical’s rich history and future outlook.” commented Gerald W. Bottero from PENTAX Medical.
The final organized MILES FOR HEALTH run took place on 27th November in the UK, and was accompanied by anniversary celebrations at PENTAX Medical offices across the globe – from Germany to Singapore. Following this, submissions were closed and the grand total calculated ready for a final ceremony at World Cancer Research Fund headquarters in London, UK on 28th November 2019.
World Cancer Research Fund’s CEO, Rachael Gormley said: "We’d like to thank PENTAX Medical for their incredibly generous donation. It will help to support our researchers and their work into cancer prevention and survival, helping people around the world live longer, stronger, cancer-free lives. PENTAX Medical is a great example of how the health care industry can really help make a difference. From everyone at World Cancer Research Fund – thank you."
Looking forward to the next 100 years and beyond, PENTAX Medical’s mission continues; innovating and developing leading-edge optical technologies that aid the global medical community, providing quality, cutting-edge and easy-to-use endoscopic products and services. From screening to diagnosis and into therapy, PENTAX Medical offers clinicians various advanced solutions that support each step of the clinical pathway. Together with its customers and partners around the world, PENTAX Medical is committed to help improve the detection, diagnosis and treatment of cancer.
About PENTAX Medical
PENTAX Medical is a division of HOYA Group. Its mission is to improve the standard of patient care and quality of healthcare delivery by providing the best endoscopic products and services with a focus on QUALITY, CLINICALLY RELEVANT INNOVATION, and SIMPLICITY. Through leading edge R&D and manufacturing, PENTAX Medical provides endoscopic imaging devices and solutions to the global medical community. Headquartered in Japan, PENTAX Medical has a worldwide focus and presence with R&D, regional sales, service, and in-country facilities around the globe.
For more information, please visit: www.pentaxmedical.com.
About World Cancer Research Fund
World Cancer Research Fund is one of the world’s leading cancer prevention charities, and is dedicated to funding life-changing research into the prevention of cancer through diet and lifestyle. We cut through the jargon to turn the latest global research on cancer prevention and survival into practical, straightforward advice and information, helping anyone who wants to reduce their risk of developing cancer to make fully informed lifestyle choices.
Find out more: www.wcrf-uk.org
Does Secondary Furlow Palatoplasty Worsen Palatal Motion?
Click to learn how Furlow Palatoplasty potentially misaligns/scars soft palate musculature.
Posted Mar 15, 2017More
Optimizing Diagnostic Yields of EUS-Guided Liver Biopsy: An Assessment of Tissue Acquisition Techniques and Needle Types
Click to read more about EUS-Guided tissue acquisition assessment techniques and needle types.
Posted Mar 14, 2017More